Menu

Latest news & events

Uyên Châu Nguyên wins UM Dissertation Prize 2025

Uyên Châu Nguyên wins UM Dissertation Prize 2025

29 January 2026

During the Dies Natalis of Maastricht University, Uyên Châu Nguyên received the UM Dissertation Prize 2025.

Read more
Global research network launched to study menopause and heart health

Global research network launched to study menopause and heart health

20 January 2026

Ten international health research funders, including the Dutch Heart Foundation, are investing $10 million in a new global research network to improve early prevention of cardiovascular disease in women. The initiative focuses on understanding how menopause affects heart health and how early intervention can reduce risk.

Read more
More newsMore events
Carim Maastricht
Carim Maastricht

Dionne Braeken

Research Assistant

Dr. Dionne Braeken studied nursing at Zuyd Hogeschool, followed by a master in Health Education and Promotion at Maastricht University. Her PhD thesis was on Respiratory infections, exacerbations and the microbiome in COPD. Currently, she works as Thrombosis vigilance officer at the Thrombosis Expertise Center (TEC) of the MUMC+ Heart+Vascular Center.

Dionne braeken dsf2346 kopie

Department: Thrombosis Expertise Center
P. Debyelaan 25 6229 HX Maastricht
Room number: 3.C2.006
T: +31(0)43 387 76 71

  • 2024
    • Visser, C., Berentschot, J. C., de Jong, C. M. M., Antoni, M. L., Bek, L. M., van den Berg-Emons, R. J. G., van den Borst, B., ten Cate, H., ten Cate-Hoek, A. J., Braeken, D. C. W., Geelhoed, J. J. M., Heijenbrok-Kal, M. H., van Kuijk, S. M. J., Kroft, L. J. M., Leentjens, J., Roukens, A. H. E., Cannegieter, S. C., Klok, F. A., Kruip, M. J. H. A., ... Dutch COVID & Thrombosis Coalition (2024). The impact of pulmonary embolism on health outcomes of COVID-19 at 3 months after hospitalization. Research and practice in thrombosis and haemostasis, 8(7), Article e102573. https://doi.org/10.1016/j.rpth.2024.102573
  • 2023
    • Braeken, D. C. W., Bavalia, R., Henskens, Y. M. C., Cate, H. T., Hengeveld, R. C. C., Hutten, B. A., Middeldorp, S., Coppens, M., & Stroobants, A. K. (2023). Clinical characteristics of patients with direct oral anticoagulant (DOAC) levels outside expected ranges: A retrospective chart study. Thrombosis Update, 11(1), Article 100139. https://doi.org/10.1016/j.tru.2023.100139
  • 2022
    • Gulpen, A. J. W., Braeken, D. C. W., Schalla, S., Ten Cate, H., Crijns, H. J., & Ten Cate-Hoek, A. J. (2022). Long-Term Adherence to Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Comparative Cross-Sectional Study. Acta Haematologica, 145(5), 476-483. https://doi.org/10.1159/000524094
  • 2021
    • Hulshof, A. M., Braeken, D. C. W., Ghossein-Doha, C., van Santen, S., Sels, J. W. E. M., Kuiper, G. J. A. J. M., van der Horst, I. C. C., ten Cate, H., van Bussel, B. C. T., Olie, R. H., & Henskens, Y. M. C. (2021). Hemostasis and fibrinolysis in COVID-19 survivors 6 months after intensive care unit discharge. Research and practice in thrombosis and haemostasis, 5(6), Article e12579. https://doi.org/10.1002/rth2.12579
    • Livneh, N., Braeken, D., Drozdinsky, G., Gafter-Gvili, A., Seelig, J., Rozovski, U., Berger, T., Raanani, P., Falanga, A., ten Cate, H., Spectre, G., & Leader, A. (2021). Anticoagulation in patients with atrial fibrillation, thrombocytopenia and hematological malignancy. Journal of Thrombosis and Thrombolysis, 52(2), 590-596. https://doi.org/10.1007/s11239-021-02393-8
    • Stals, M. A. M., Kaptein, F. H. J., Bemelmans, R. H. H., van Bemmel, T., Boukema, I. C., Braeken, D. C. W., Braken, S. J. E., Bresser, C., Cate, H. T., Deenstra, D. D., Dooren, Y. P. A. V., Faber, L. M., Grootenboers, M. J. J. H., Haan, L. R. D., Haazer, C., Sol, A. I. D., Kelliher, S., Koster, T., Kroft, L. J. M., ... Dutch COVID & Thrombosis Coalition (DCTC) (2021). Ruling out Pulmonary Embolism in Patients with (Suspected) COVID-19-A Prospective Cohort Study. TH open : companion journal to thrombosis and haemostasis, 5(3), e387-e399. https://doi.org/10.1055/s-0041-1735155
    • Braeken, D. C. W., Essig, A., Panning, M., Hoerster, R., Nawrocki, M., Dalhoff, K., Suttorp, N., Welte, T., Pletz, M. W., Witzenrath, M., Rohde, G. G. U., Rupp, J., & CAPNETZ Study Grp (2021). Shift in bacterial etiology from the CAPNETZ cohort in patients with community-acquired pneumonia: data over more than a decade. Infection, 49(3), 533-537. https://doi.org/10.1007/s15010-021-01605-w
    • Bavalia, R., Veenhuizen, J. E., Hengeveld, R. C. C., Braeken, D., Gulpen, A. J. W., Ten Cate, H., Middeldorp, S., Henskens, Y. M. C., Hutten, B. A., Coppens, M., & Stroobants, A. K. (2021). Direct oral anticoagulant blood level monitoring in daily practice. Thrombosis Update, 3, Article 100049. https://doi.org/10.1016/j.tru.2021.100049
  • 2019
    • Radtke, T., Crook, S., Kaltsakas, G., Louvaris, Z., Berton, D., Urquhart, D. S., Kampouras, A., Rabinovich, R. A., Verges, S., Kontopidis, D., Boyd, J., Tonia, T., Langer, D., De Brandt, J., Goertz, Y. M. J., Burtin, C., Spruit, M. A., Braeken, D. C. W., Dacha, S., ... Hebestreit, H. (2019). ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases. European Respiratory Review, 28(154), Article 1901441. https://doi.org/10.1183/16000617.0101-2018
    • Oshagbemi, O. A., Franssen, F. M. E., van Kraaij, S., Braeken, D. C. W., Wouters, E. F. M., Maitland-van der Zee, A. H., Driessen, J. H. M., & de Vries, F. (2019). Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD). COPD, 16(2), 152-159. https://doi.org/10.1080/15412555.2019.1608172
  • 2018
    • Oshagbemi, O. A., Franssen, F. M. E., Braeken, D. C. W., Henskens, Y., Wouters, E. F. M., Maitland-van der Zee, A.-H., Burden, A. M., & de Vries, F. (2018). Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality. Pharmacoepidemiology and Drug Safety, 27(11), 1191-1199. https://doi.org/10.1002/pds.4655
    • Sprooten, R. T. M., Lenaerts, K., Braeken, D. C. W., Grimbergen, I., Rutten, E. P., Wouters, E. F. M., & Rohde, G. G. U. (2018). Increased Small Intestinal Permeability during Severe Acute Exacerbations of COPD. Respiration, 95(5), 334-342. https://doi.org/10.1159/000485935
  • 2017
    • Braeken, D. C. W., Spruit, M. A., Houben-Wilke, S., Smid, D. E., Rohde, G. G. U., Wouters, E. F. M., & Franssen, F. M. E. (2017). Impact of exacerbations on adherence and outcomes of pulmonary rehabilitation in patients with COPD. Respirology, 22(5), 942-949. https://doi.org/10.1111/resp.12987
    • Oshagbemi, O. A., Burden, A. M., Braeken, D. C. W., Henskens, Y., Wouters, E. F. M., Driessen, J. H. M., Maitland-van der Zee, A. H., de Vries, F., & Franssen, F. M. E. (2017). Stability of Blood Eosinophils in Patients with Chronic Obstructive Pulmonary Disease and in Control Subjects, and the Impact of Sex, Age, Smoking, and Baseline Counts. American Journal of Respiratory and Critical Care Medicine, 195(10), 1402-1404. https://doi.org/10.1164/rccm.201701-0009LE
    • Braeken, D. C. W., Franssen, F. M. E., von Baum, H., Schuette, H., Pletz, M. W., Rupp, J., Stassen, F., Mooij, M. J., Rohde, G. G. U., & CAPNETZ Study Grp (2017). Bacterial aetiology and mortality in COPD patients with CAP: results from the German Competence Network, CAPNETZ. International Journal of Tuberculosis and Lung Disease, 21(2), 236-243. https://doi.org/10.5588/ijtld.16.0567
    • Braeken, D. C. W., Rohde, G. G. U., Franssen, F. M. E., Driessen, J. H. M., van Staa, T. P., Souverein, P. C., Wouters, E. F. M., & de Vries, F. (2017). Risk of community-acquired pneumonia in chronic obstructive pulmonary disease stratified by smoking status: a population-based cohort study in the United Kingdom. International journal of chronic obstructive pulmonary disease, 12, 2425-2432. https://doi.org/10.2147/COPD.S138435
    • de Vries, F., Rohde, G. G. U., Braeken, D. C. W., van Staa, T. P., Souverein, P. C., Wouters, E. F. M., & Franssen, F. M. E. (2017). Upregulated pneumococcal adhesion molecule (platelet-activating factor receptor) may predispose COPD patients to community-acquired pneumonia: Author's Reply. International journal of chronic obstructive pulmonary disease, 12, 3113-3113. https://doi.org/10.2147/COPD.S151142
  • 2016
    • Braeken, D. C. W., Houben - Wilke, S., Smid, D. E., Rohde, G., Drijkoningen, J. J. C., Wouters, E., Spruit, M., & Franssen, F. (2016). Sputum microbiology predicts health status in COPD. International journal of chronic obstructive pulmonary disease, 11(1), 2741-2748. https://doi.org/10.2147/COPD.S117079
Overview